{"id":"https://openalex.org/W2997076745","doi":"https://doi.org/10.1097/mcg.0000000000001278","title":"Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients","display_name":"Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients","publication_year":2020,"publication_date":"2020-01-03","ids":{"openalex":"https://openalex.org/W2997076745","doi":"https://doi.org/10.1097/mcg.0000000000001278","mag":"2997076745","pmid":"https://pubmed.ncbi.nlm.nih.gov/31904681"},"language":"en","primary_location":{"id":"doi:10.1097/mcg.0000000000001278","doi":"https://doi.org/10.1097/mcg.0000000000001278","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mcg.0000000000001278","pdf_url":null,"source":{"id":"https://openalex.org/S69483707","display_name":"Journal of Clinical Gastroenterology","issn_l":"0192-0790","issn":["0192-0790","1539-2031"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028215297","display_name":"Nagwan Salama Farhoud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nagwan S. Farhoud","raw_affiliation_strings":["Drug and Poison Information Centre, College of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug and Poison Information Centre, College of Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030770573","display_name":"Osama Mohamed Ibrahim","orcid":"https://orcid.org/0000-0002-2868-039X","observed_orcids":["https://orcid.org/0000-0002-2868-039X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osama M. Ibrahim","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114080551","display_name":"Sherif E. Ezzat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21376657","display_name":"Tanta University","ror":"https://ror.org/016jp5b92","country_code":"EG","type":"education","lineage":["https://openalex.org/I21376657"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Sherif E. Ezzat","raw_affiliation_strings":["Department of Gastroenterology, College of Medicine, Tanta University, Tanta, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, College of Medicine, Tanta University, Tanta, Egypt","institution_ids":["https://openalex.org/I21376657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5028215297"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9646,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.84848485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"54","issue":"9","first_page":"806","last_page":"812"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/helicobacter-pylori-infection","display_name":"Helicobacter pylori infection","score":0.9890000224113464},{"id":"https://openalex.org/keywords/sequential-therapy","display_name":"sequential therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/lansoprazole","display_name":"lansoprazole","score":0.7559999823570251},{"id":"https://openalex.org/keywords/clarithromycin","display_name":"clarithromycin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/amoxicillin","display_name":"amoxicillin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tinidazole","display_name":"tinidazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/eradication-rate","display_name":"eradication rate","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9309999942779541},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5929999947547913},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.7279999852180481},{"id":"https://openalex.org/keywords/egyptian-patients","display_name":"Egyptian patients","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9225398302078247},{"id":"https://openalex.org/C2778715759","wikidata":"https://www.wikidata.org/wiki/Q254296","display_name":"Lansoprazole","level":3,"score":0.8820232152938843},{"id":"https://openalex.org/C2779708577","wikidata":"https://www.wikidata.org/wiki/Q201928","display_name":"Amoxicillin","level":3,"score":0.6813374161720276},{"id":"https://openalex.org/C2776409635","wikidata":"https://www.wikidata.org/wiki/Q180556","display_name":"Helicobacter pylori","level":2,"score":0.6575549840927124},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6409534811973572},{"id":"https://openalex.org/C2780626017","wikidata":"https://www.wikidata.org/wiki/Q1321320","display_name":"Tinidazole","level":4,"score":0.6355485320091248},{"id":"https://openalex.org/C2776962512","wikidata":"https://www.wikidata.org/wiki/Q118551","display_name":"Clarithromycin","level":3,"score":0.6295626759529114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6146696209907532},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5939600467681885},{"id":"https://openalex.org/C2777172195","wikidata":"https://www.wikidata.org/wiki/Q186604","display_name":"Urea breath test","level":4,"score":0.5647528767585754},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5265976190567017},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.46182969212532043},{"id":"https://openalex.org/C2775981797","wikidata":"https://www.wikidata.org/wiki/Q638366","display_name":"Breath test","level":3,"score":0.41231778264045715},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.23512107133865356},{"id":"https://openalex.org/C2908868296","wikidata":"https://www.wikidata.org/wiki/Q180556","display_name":"Helicobacter pylori infection","level":3,"score":0.2134668231010437},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.10484504699707031},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.05778360366821289},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000658","descriptor_name":"Amoxicillin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004534","descriptor_name":"Egypt","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016480","descriptor_name":"Helicobacter pylori","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016481","descriptor_name":"Helicobacter Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017291","descriptor_name":"Clarithromycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mcg.0000000000001278","doi":"https://doi.org/10.1097/mcg.0000000000001278","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mcg.0000000000001278","pdf_url":null,"source":{"id":"https://openalex.org/S69483707","display_name":"Journal of Clinical Gastroenterology","issn_l":"0192-0790","issn":["0192-0790","1539-2031"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Gastroenterology","raw_type":"journal-article"},{"id":"pmid:31904681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31904681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical gastroenterology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1022964824","https://openalex.org/W1484106576","https://openalex.org/W1608682610","https://openalex.org/W1998099756","https://openalex.org/W2004282686","https://openalex.org/W2010672429","https://openalex.org/W2016484001","https://openalex.org/W2041638520","https://openalex.org/W2071797781","https://openalex.org/W2102752661","https://openalex.org/W2108185286","https://openalex.org/W2133281678","https://openalex.org/W2138283672","https://openalex.org/W2148685950","https://openalex.org/W2152211277","https://openalex.org/W2159142230","https://openalex.org/W2183787411","https://openalex.org/W2185653363","https://openalex.org/W2189592482","https://openalex.org/W2211884780","https://openalex.org/W2290736004","https://openalex.org/W2411670001","https://openalex.org/W2491408533","https://openalex.org/W2559910960","https://openalex.org/W2560839053","https://openalex.org/W2570938003","https://openalex.org/W2891911635","https://openalex.org/W4232123077","https://openalex.org/W6686267736","https://openalex.org/W6730236949"],"related_works":["https://openalex.org/W2211884780","https://openalex.org/W3179670381","https://openalex.org/W2041638520","https://openalex.org/W2373206015","https://openalex.org/W2159142230","https://openalex.org/W2891911635","https://openalex.org/W2884636519","https://openalex.org/W2964819443","https://openalex.org/W3032641013","https://openalex.org/W2095934010"],"abstract_inverted_index":{"GOALS:":[0],"The":[1,151,177],"aim":[2],"of":[3,109,142],"this":[4],"study":[5],"was":[6,154,180],"to":[7,55],"clarify":[8],"whether":[9],"10-day":[10,61,157],"or":[11,65,84,103,201],"14-day":[12,57,66,161,193,211],"sequential":[13],"therapy":[14,20],"(ST)":[15],"can":[16],"replace":[17,220],"conventional":[18],"triple":[19,189],"(TT)":[21],"as":[22,222],"a":[23,223],"first-line":[24,224],"treatment":[25,71,107,128,225],"in":[26,173,230],"Egypt.":[27],"BACKGROUND:":[28],"Antimicrobial":[29],"resistance":[30],"has":[31],"decreased":[32],"the":[33,56,134,140,174,214],"eradication":[34,152],"rates":[35],"for":[36,48,82,101,122,165,187,199,226],"Helicobacter":[37],"pylori":[38,50,228],"infection":[39,51,229],"worldwide.":[40],"MATERIALS":[41],"AND":[42],"METHODS:":[43],"Patients":[44],"who":[45],"tested":[46],"positive":[47],"H.":[49,227],"were":[52,131,148],"randomly":[53],"assigned":[54],"triple-therapy":[58],"group":[59,63,68],"(n=34),":[60,64],"ST":[62,67,212,218],"(n=35).":[69],"Sequential":[70,197],"includes":[72],"lansoprazole":[73,89,110],"30":[74,90,111],"mg":[75],"and":[76,95,116,146,163,192],"amoxicillin":[77,117],"1000":[78,118],"mg,":[79,91,94,98,112,115,119],"both":[80],"twice":[81,100,121],"5":[83,102],"7":[85,104],"days,":[86],"followed":[87],"by":[88,133],"clarithromycin":[92,113],"500":[93,97,114],"tinidazole":[96],"each":[99,120],"days.":[105,124],"Triple":[106],"consists":[108],"14":[123,202],"Six":[125],"weeks":[126],"after":[127],"discontinuation,":[129],"patients":[130],"examined":[132],"urea":[135],"breath":[136],"test.":[137],"Eradication":[138],"rates,":[139],"incidence":[141],"adverse":[143,170],"effects,":[144],"compliance,":[145],"cost-effectiveness":[147,178],"evaluated.":[149],"RESULTS:":[150],"rate":[153],"90%":[155],"with":[156,160,210],"ST,":[158,162,194],"96.7%":[159],"63.3%":[164],"TT":[166,221],"(P=0.001).":[167],"Mild":[168],"tolerated":[169],"effects":[171],"occurred":[172],"3":[175],"groups.":[176],"ratio":[179],"2194":[181],"LE,":[182,184],"1241":[183],"1157":[185],"LE":[186],"standard":[188,208],"therapy,":[190],"10-day,":[191],"respectively.":[195],"CONCLUSIONS:":[196],"therapies":[198],"10":[200],"days":[203],"are":[204],"more":[205],"cost-effective":[206],"than":[207],"TT,":[209],"being":[213],"most":[215],"cost-effective.":[216],"Accordingly,":[217],"might":[219],"Egyptian":[231],"patients.":[232]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-01-10T00:00:00"}